America is facing a doctor shortage, and this startup has raised $109M to fix it.
It’s called Akido Labs, founded by Prashant Samant (ex-McKinsey) and Jared Goodner.
Their goal is to make every doctor 5x more productive using AI to run medical appointments and draft diagnoses.
Here’s what they’re betting 100 million on:
▶ AI-powered interviews
Patients speak to a medical assistant, their tool Scope AI transcribes and analyzes. The system even generates follow-up questions - like a trained doctor would.
By the end, it produces a summary, likely diagnosis, alternatives, and a treatment plan.
▶ Doctor as reviewer
Instead of conducting the full visit, doctors now review ScopeAI’s recommendations in their own time. They approve, correct, or reject the output - cutting hours of repetitive work.
This lets doctors see 4–5x more patients.
▶ Real-world impact
ScopeAI is already being used in cardiology, endocrinology, and primary care clinics. Akido’s street medicine team in LA now gets certain meds to patients within 24 hours - something “unheard of” before.
There’s been backlash against ‘AI Doctors’ before.
But ScopeAI isn’t that. Every diagnosis and treatment plan is still signed off by a licensed physician. So this seems like a good middle ground.
They’ll still need to figure out automation bias (doctors over-trusting AI) and regulatory grey zones.
But if it works, ScopeAI could become a blueprint for scaling healthcare access without scaling the number of doctors.
Would you be comfortable if your first medical diagnosis came from an AI system like this?
